Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Cognitive impairment (CI) is very common in patients with Parkinson’s Disease (PD) and progressively develops on a spectrum from mild cognitive impairment (PD-MCI) to full dementia (PDD). Identification of PD patients at risk of developing cognitive decline, therefore, is unmet need in the clinic to...

Descripción completa

Detalles Bibliográficos
Autores principales: Arıkan, Muzaffer, Demir, Tuğçe Kahraman, Yıldız, Zeynep, Nalbantoğlu, Özkan Ufuk, Korkmaz, Nur Damla, Yılmaz, Nesrin H., Şen, Aysu, Özcan, Mutlu, Muth, Thilo, Hanoğlu, Lütfü, Yıldırım, Süleyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657361/
https://www.ncbi.nlm.nih.gov/pubmed/37980417
http://dx.doi.org/10.1038/s41522-023-00452-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657361/
https://www.ncbi.nlm.nih.gov/pubmed/37980417
http://dx.doi.org/10.1038/s41522-023-00452-x

Ejemplares similares